{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360021390761890432.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1007/s00592-023-02214-9"}},{"identifier":{"@type":"URI","@value":"https://link.springer.com/content/pdf/10.1007/s00592-023-02214-9.pdf"}},{"identifier":{"@type":"URI","@value":"https://link.springer.com/article/10.1007/s00592-023-02214-9/fulltext.html"}},{"identifier":{"@type":"PMID","@value":"38006524"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Association between continuous glucose monitoring-derived glycemic control indices and urinary biomarkers of diabetic kidney disease: Hyogo Diabetes Hypoglycemia Cognition Complications study"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:title>Abstract</jats:title><jats:sec>\n                <jats:title>Aims</jats:title>\n                <jats:p>Glomerular damage and proximal tubular damage play an important role in the pathogenesis of diabetic kidney disease. This study aimed to investigate the relationship between the urinary markers of proximal tubular injury, including urinary liver-type fatty acid-binding protein-to-creatinine ratio (uL-FABP/Cr) and urinary <jats:italic>N</jats:italic>-acetyl-β-<jats:sc>d</jats:sc>-glucosaminidase-to-creatinine ratio (uNAG/Cr), and glycemic control status.</jats:p>\n              </jats:sec><jats:sec>\n                <jats:title>Methods</jats:title>\n                <jats:p>This cross-sectional study included 245 and 39 patients with type 2 diabetes mellitus (T2DM) and non-T2DM (NDM), respectively. The participants of this study were fitted with retrospective CGM, and glycemic control indices, such as time in range (TIR) and glycemia risk index (GRI), were calculated.</jats:p>\n              </jats:sec><jats:sec>\n                <jats:title>Results</jats:title>\n                <jats:p>The results were presented as medians (interquartile ranges). The uL-FABP/Cr was significantly higher in the microalbuminuria than in the normo-albuminuria group [4.2 (2.7–7.1) and 2.2 (1.4–3.4) μg/gCr, respectively, <jats:italic>P</jats:italic> < 0.001], while the uNAG/Cr in the normo-albuminuria group [6.3 (4.5–10.1) U/gCr] was significantly higher than that in the NDM group [5.3 (3.8–6.3) U/gCr, <jats:italic>P</jats:italic> = 0.048] but significantly lower than that in the microalbuminuria group [9.2 (6.4–11.1) U/gCr, <jats:italic>P</jats:italic> = 0.004]. The multivariate logistic regression analysis indicated that CGM-derived TIR was significantly associated with the urinary albumin-to-creatinine ratio [uAlb/Cr, odds ratio (OR) 0.985, 95% confidence interval (CI) 0.971–0.998, <jats:italic>P</jats:italic> = 0.029] and uNAG/Cr (OR 0.973, 95% CI 0.957–0.989, <jats:italic>P</jats:italic> = 0.001) independent of renal function. GRI was similarly associated with uAlb/Cr and uNAG/Cr.</jats:p>\n              </jats:sec><jats:sec>\n                <jats:title>Conclusion</jats:title>\n                <jats:p>The findings of this study indicated that uNAG/Cr was elevated before albuminuria development and was associated with CGM-derived TIR and GRI.</jats:p>\n              </jats:sec>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380021390761890560","@type":"Researcher","foaf:name":[{"@value":"Ayako Takagi"}]},{"@id":"https://cir.nii.ac.jp/crid/1420845751157871872","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"00792194"},{"@type":"NRID","@value":"1000000792194"},{"@type":"NRID","@value":"9000406201591"}],"foaf:name":[{"@value":"Yoshiki Kusunoki"}]},{"@id":"https://cir.nii.ac.jp/crid/1420285329317575808","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"60884864"},{"@type":"NRID","@value":"1000060884864"}],"foaf:name":[{"@value":"Mana Ohigashi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390761890468","@type":"Researcher","foaf:name":[{"@value":"Keiko Osugi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390761890441","@type":"Researcher","foaf:name":[{"@value":"Chikako Inoue"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390761890446","@type":"Researcher","foaf:name":[{"@value":"Maki Inoue"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390761890445","@type":"Researcher","foaf:name":[{"@value":"Taku Tsunoda"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390761890444","@type":"Researcher","foaf:name":[{"@value":"Manabu Kadoya"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390761890442","@type":"Researcher","foaf:name":[{"@value":"Kosuke Konishi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390761890565","@type":"Researcher","foaf:name":[{"@value":"Tomoyuki Katsuno"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390761890460","@type":"Researcher","foaf:name":[{"@value":"Hidenori Koyama"}]}],"publication":{"publicationIdentifier":[{"@type":"EISSN","@value":"14325233"}],"prism:publicationName":[{"@value":"Acta Diabetologica"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2023-11-25","prism:volume":"61","prism:number":"4","prism:startingPage":"413","prism:endingPage":"423"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","dc:rights":["https://creativecommons.org/licenses/by/4.0","https://creativecommons.org/licenses/by/4.0"],"url":[{"@id":"https://link.springer.com/content/pdf/10.1007/s00592-023-02214-9.pdf"},{"@id":"https://link.springer.com/article/10.1007/s00592-023-02214-9/fulltext.html"}],"createdAt":"2023-11-25","modifiedAt":"2024-03-26","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Original%20Article","dc:title":"Original Article"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040577277050550016","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"23K08021"},{"@type":"JGN","@value":"JP23K08021"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23K08021/"}],"notation":[{"@language":"ja","@value":"睡眠の「質」低下は心・代謝連関にどのようなメカニズムで影響するのか？"}]},{"@id":"https://cir.nii.ac.jp/crid/1040850857192994816","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"21K17297"},{"@type":"JGN","@value":"JP21K17297"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21K17297/"}],"notation":[{"@language":"ja","@value":"糖尿病患者における糖代謝、睡眠障害と心左室拡張機能障害の関連"},{"@language":"en","@value":"Association of Glucose Metabolism, Sleep Disorders and Left Ventricular Diastolic Dysfunction in Diabetes Mellitus Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1040854882529261696","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"22K10541"},{"@type":"JGN","@value":"JP22K10541"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22K10541/"}],"notation":[{"@language":"ja","@value":"2型糖尿病患者における糖代謝、睡眠障害、心血管疾患の相互関連"},{"@language":"en","@value":"Mutual relationship between glucose metabolism, sleep disturbances, and cardiovascular disease in patients with type 2 diabetes mellitus"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002216313711104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011144709035904","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical Significance of Urinary Liver-Type Fatty Acid–Binding Protein in Diabetic Nephropathy of Type 2 Diabetic Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145625970048","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A sol particle homogeneous immunoassay for measuring serum cystatin C"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013172089841152","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017285975247232","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Molecular mechanisms and therapeutic targets for diabetic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017290179926912","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Lysosomal dysfunction–induced autophagic stress in diabetic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360018992704386176","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Continuous glucose monitoring and metrics for clinical trials: an international consensus statement"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021393776645504","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Urinary biomarker N-acetyl-β-D-glucosaminidase can predict severity of renal damage in diabetic nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021396339353600","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283690825884800","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Urinary liver type fatty acid binding protein in diabetic nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619857160832","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function”"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298761953036032","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"11. Chronic Kidney Disease and Risk Management: <i>Standards of Care in Diabetes—2023</i>"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302868275810304","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Association between nonalbumin proteinuria and renal tubular damage of N-acetyl-β-d-glucosaminidase and its clinical relevance in patients with type 2 diabetes without albuminuria"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302868276619008","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Differential correlation between time in range and eGFR or albuminuria in type 2 diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302868276909440","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302871495142528","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Urinary N-acetyl-β-D-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302871495740288","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Serum Cystatin C and Tubular Urinary Enzymes as Biomarkers of Renal Dysfunction in Type 2 Diabetes Mellitus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092752051968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo Diabetes Hypoglycemia Cognition Complications study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095410492288","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A more tubulocentric view of diabetic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584342598602240","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Urinary <i><scp>N</scp></i>‐acetyl‐β‐<scp>d</scp>‐Glucosaminidase Levels are Positively Correlated With 2‐Hr Plasma Glucose Levels During Oral Glucose Tolerance Testing in Prediabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584342599037568","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Microalbuminuria: causes and implications"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584342599310720","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Challenging the conventional wisdom on diabetic nephropathy: Is microalbuminuria the earliest event?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584342599913088","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Association Between Continuous Glucose Monitoring-Derived Glycemia Risk Index and Albuminuria in Type 2 Diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584344417071232","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855568925304064","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569124962816","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Renal L-Type Fatty Acid–Binding Protein in Acute Ischemic Injury"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855571006359040","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Proximal Tubulopathy: Prime Mover and Key Therapeutic Target in Diabetic Kidney Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861293105026560","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines"}]},{"@id":"https://cir.nii.ac.jp/crid/1360862720849926656","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Early renal structural changes and potential biomarkers in diabetic nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520126639744","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Risk Factors for Renal Dysfunction in Type 2 Diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699996140538112","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Tubular and Glomerular Injury in Diabetes and the Impact of ACE Inhibition"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699996253272832","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Association Between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468514419200","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Urinary Excretion of Fatty Acid-Binding Protein Reflects Stress Overload on the Proximal Tubules"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469212054272","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effects of renal sorbitol accumulation on urinary excretion of enzymes in                hyperglycaemic rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945755445248","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420049188608","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420404872832","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893736855424","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"UK prospective diabetes study (UKPDS)"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894673500032","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"International Consensus on Use of Continuous Glucose Monitoring"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844844310784","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Response of urinary N-acetyl-β-d-glucosaminidase to rapid decreases in blood glucose"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845782969856","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Determination of urinary enzymes as a marker of early renal damage in diabetic patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320689745024","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233271171363328","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Association Between Pulse Wave Velocity and a Marker of Renal Tubular Damage (<scp>N</scp>‐Acetyl‐β‐<scp>D</scp>‐Glucosaminidase) in Patients Without Diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1523951030061134848","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"GUIDELINE : Japanese Clinical Practice Guideline for Diabetes 2019"}]},{"@id":"https://cir.nii.ac.jp/crid/1571980074193578496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Revised equations for estimated GFR from serum creatinine in Japan"},{"@value":"Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan"},{"@value":"Revised equations for estimated GFR from serum creatinine in Japan. American journal of kidney diseases: the official journal of the"},{"@value":"Revised equations for estimating glomerular filtration rate (GFR) from serum creatinine in Japan"},{"@value":"Hishida A; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan"},{"@value":"Revised equation for estimated GFR from serum creatinine in Japan"},{"@value":"Collaborators developing the Japanese equation for estimating GFR. Revised equation for estimated GFR from serum creatinine in Japan"},{"@value":"Collaborators developing the Japanese equation for estimated GFR"},{"@value":"Japanese equation for estimated GFR"},{"@value":"Revised equation for estimating glomerular filtration rate (GFR) from serum creatinin in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/2050307417129978880","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A digest of the Evidence-Based Clinical Practice Guideline for Nephrotic Syndrome 2020"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1007/s00592-023-02214-9"},{"@type":"KAKEN","@value":"PRODUCT-24934129"},{"@type":"KAKEN","@value":"PRODUCT-25554326"},{"@type":"KAKEN","@value":"PRODUCT-25726417"},{"@type":"OPENAIRE","@value":"doi_dedup___::7cb8c23eb9a725af676c7df1d4a416c8"}]}